NDC 0409-1623
Butorphanol Tartrate
Butorphanol Tartrate
Butorphanol Tartrate is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Butorphanol Tartrate.
| Product ID | 0409-1623_695b7874-f6f9-4a28-8d0d-4d91f9ad3bd4 |
| NDC | 0409-1623 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Butorphanol Tartrate |
| Generic Name | Butorphanol Tartrate |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2005-09-23 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA074626 |
| Labeler Name | Hospira, Inc. |
| Substance Name | BUTORPHANOL TARTRATE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |